Newsfeeds - Spark Newswire

1 minute read

Analyst Views Novo Nordisk’s Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly’s Tirzepatide

Today, 2:53 AM

Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.

AMGN

1 minute read

Novartis CEO Refutes Recent Report Of Weighing Options For Ophthalmology, Respiratory Units

By Vandana Singh

Today, 2:53 AM

Novartis AG (NYSE: NVS) said it would narrow its focus on five core therapeutic areas, including cardiovascular, immunology, neurodegenerative diseases, solid tumors, and hematology.

NVS

1 minute read

Traders Circulate Post Suggesting Novartis AG ‘Misses On 2nd Interim For NATALEE Trial. Not A Good Sign For Differentiation Vs Abema’

By Benzinga Newsdesk

Today, 2:53 AM

https://twitter.com/pharmacreep/status/1612487217800167424

NVS

1 minute read

GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca

By Vandana Singh

Today, 2:53 AM

GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth $1 billion-$2.5 billion and avoid getting into a 'bidding war.'

GSK

5 minute read

Elon Musk Tells Employees Tesla Will Be ‘Most Valuable Company On Earth, Sam Bankman-Fried Set To Enter Plea On Fraud Case, Twitter ‘Should Feel Faster’: Today’s Top Stories

By Vandana Singh

Today, 2:53 AM

Reuters

$BNB

1 minute read

Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug

By Vandana Singh

Today, 2:53 AM

Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower blood pressure and reduce the risk of strokes.

CVS

1 minute read

News

5 Value Stocks In The Healthcare Sector

By Benzinga Insights

Today, 2:53 AM

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of…

ABOS

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 2:53 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ALGN

1 minute read

A Bullish Sign Appears On Novartis’s Chart

By Benzinga Insights

Today, 2:53 AM

If history is any guide, there may be good fortune ahead for shares of Novartis (NYSE:NVS). A so-called…

NVS

1 minute read

Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says

By Vandana Singh

Today, 2:53 AM

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) has announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. JMP has…

AZN